⌘K

Login Start Free

Home/Filings/4/0001213900-24-054781

4//SEC Filing

Gabay Avraham 4

Accession 0001213900-24-054781

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:15 PM ET

Size

5.1 KB

Accession

0001213900-24-054781

Insider Transaction Report

Form 4

Period: 2024-06-21

ORAMED PHARMACEUTICALS INC.ORMP

Chief Financial Officer

Transactions

Award
Common Stock
2024-06-21+140,040→ 0 total

Footnotes (1)

[F1]Represents a grant of 140,040 Restricted Stock Units ("RSUs"), of which 93,360 will vest on June 18, 2026 and the remaining 46,680 will vest in four equal quarterly installments of 11,670 starting September 18, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001777328

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 4:15 PM ET
Size: 5.1 KB

View on SEC.gov